OSRH · OSR Health, Inc. · Executive Compensation
$0.17
+0.05 (+43.78%)
At close · Aug 26
View the 10-K filed Mar 31, 2026
Customer concentration
— top 3 customers 95% of revenue
3 customers — 95% of revenue
“Three main customers of RMC have in recent years represented approximately 95% of RMC's total sales.”
Market Cap
$4.09M
Shares
35.12M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Kuk Hyoun Hwang | Chairman of the Board of Directors | $400,000 |
| Constance Höfer | Chief Scientific Officer | $345,000 |
| Gihyoun Bang | Chief Financial Officer | $300,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gihyoun Bang | Chief Financial Officer | $47,367 |
| Kuk Hyoun Hwang | Chairman of the Board of Directors | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Yeiseok Kim | Chief Operating Officer | Appointed | 2026-04-22 |
| Sang Hyun Kim | member of the Board of Directors | Resigned | 2025-07-02 |
| Dr. Constance Höfer | Chief Scientific Officer | Appointed | 2025-03-25 |
| Sang Hoon Kim | Head of Corporate Venture Capital | Appointed | 2025-02-21 |
| Gihyoun Bang | Chief Financial Officer | Appointed | 2025-02-21 |
| Jun Chul Whang | Chief Legal Officer and Secretary | Appointed | 2025-02-21 |
| Kuk Hyoun Hwang | President and Chief Executive Officer | Appointed | 2025-02-21 |
| David J. Yoo | BLAC's Chief Financial Officer | Resigned | 2025-02-21 |
Key facts
CIK
1840425
CUSIP
68840D102
13F (30d)
12 filings
12 filers
Visit website
Investor relations